Can Fite Biofarma Ltd.

13F holders, Q3 2024 (September 30)
12holders +1
3new positions
2sold out
$2.01avg. 13F price*

At the end of Q3 2024, 12 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, up 1 from Q2 2024. 3 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($1.3M), Morgan Stanley ($102K) and Two Sigma Securities, LLC ($59K).

Company
Can Fite Biofarma Ltd.
CUSIP
13471N300
Latest filing quarter
Q4 2025

History

Number of 13F holders

05101520 Q1 2024: 8Q1 2024Q2 2024: 11Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 14Q1 2025Q2 2025: 16Q2 2025Q3 2025: 16Q3 2025Q4 2025: 15Q4 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions3$64K
Exits2$54K

All 13F filers, Q2 2024 → Q3 2024: 164,864 shares bought and 38,354 shares sold, net +126,510 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

Armistice Capital, LLC 0.03% Add +25.3% 650,000 $1.3M
Morgan Stanley 0.00% Reduce -25.3% 50,660 $102K
Two Sigma Securities, LLC 0.00% New 29,570 $59K
Rhumbline Advisers 0.00% Add +10.1% 16,945 $34K
Fifth Third Bancorp 0.00% No change 3,000 $6K
Wells Fargo & Company 0.00% New 2,500 $5K
National Bank of Canada 0.00% No change 600 $1K
Citigroup Inc. 0.00% No change 553 $1K
Activest Wealth Management 0.00% No change 200 $402
Osaic Holdings, Inc. 0.00% No change 185 $372
TD Waterhouse Canada Inc. 0.00% No change 20 $38
Avion Wealth 0.00% New 100 $0

"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.